Abiomed (GB:0H7S)

Abiomed (0H7S) Income Statement


Abiomed Income Statement

Last quarter (Q ), Abiomed's total revenue was $265.92M, an increase of 7.16% from the same quarter last year. In Q, Abiomed's net income was $106.13M. See Abiomed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 22Mar 21Mar 20Mar 19Mar 18
Total Revenue
$ 1.07B$ 1.03B$ 847.52M$ 840.88M$ 769.43M$ 593.75M
Cost of Revenue
$ 200.59M$ 188.16M$ 161.91M$ 151.31M$ 129.57M$ 98.58M
Gross Profit
$ 873.51M$ 843.60M$ 685.62M$ 689.58M$ 639.87M$ 495.17M
Operating Expense
$ 619.40M$ 586.89M$ 456.06M$ 440.36M$ 415.05M$ 338.03M
Operating Income
$ 254.11M$ 256.71M$ 229.56M$ 249.22M$ 224.81M$ 157.14M
Net Non Operating Interest Income Expense
$ 94.24M$ 49.84M$ 58.66M---
Other Income Expense
$ -47.27M$ -115.99M$ 58.66M$ 7.61M$ 38.55M$ 3.30M
Pretax Income
$ 341.16M$ 190.56M$ 288.22M$ 256.82M$ 263.36M$ 160.44M
Tax Provision
$ 74.40M$ 54.05M$ 62.70M$ 53.82M$ 4.34M$ 48.27M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ 266.76M$ 136.50M$ 225.53M$ 203.01M$ 259.02M$ 112.17M
Basic EPS
$ 5.88$ 3.00$ 5.00$ 4.49$ 5.77$ 2.54
Diluted EPS
$ 5.82$ 2.98$ 4.94$ 4.43$ 5.61$ 2.45
Basic Average Shares
$ 181.98M$ 45.45M$ 45.14M$ 45.18M$ 44.91M$ 44.15M
Diluted Average Shares
$ 183.53M$ 45.88M$ 45.67M$ 45.82M$ 46.15M$ 45.85M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
$ 3.59$ 4.44----
Rent Expense Supplemental
Total Expenses
$ 819.99M$ 775.05M$ 617.97M$ 591.66M$ 544.62M$ 436.61M
Net Income From Continuing And Discontinued Operation
$ 266.76M$ 136.50M$ 225.53M$ 203.01M$ 259.02M$ 112.17M
Normalized Income
$ 268.81M$ 219.55M$ 225.53M$ 193.40M$ 250.98M$ 109.59M
Interest Expense
$ 254.11M$ 256.71M$ 229.56M$ 249.22M$ 224.81M$ 157.14M
$ 281.67M$ 284.80M$ 253.65M$ 269.65M$ 238.93M$ 168.14M
Currency in USD

Abiomed Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis